Neurocrine Biosciences - NBIX - Low Risk Biotech X10 Stock

Companies / BioTech Jul 03, 2021 - 05:00 PM GMT

Life Sciences Biotech Smaller Cap High Risk Stocks Investing Binge

Why has my focus shifted to biotech stocks and not more tech stocks?

Firstly, I have been investing in biotech stocks for DECADES, it's just that since 2015 my focus shifted to the emerging AI mega-trend to make sure I was invested to capitalise on a trend that was clear to me would span DECADES, at the time I thought I was probably getting in late on the AI Mega-trend but clearly that is always the case! WE ALWAYS THINK we're late to the party but this trend is going to run right into the end of the 2030's

This also explains why I hold the likes of GSK and JNJ amongst a string of smaller cap biotech stocks many of which have been disappearing from my portfolio over the years usually due to being taken over as it looks likely to be the case for GW Pharma later this year. So I need to replenish this once much loved and now neglected stock sector with a string of new smaller cap high risk stocks for the next 5 to 10 years.

Secondly, our beloved AI stocks have been BID UP to high valuations, yes including Google, so they are not CHEAP, even after a 10% to 15% correction i.e. the likes of Microsoft and Amazon are discounting a lot of future earnings growth! Of course that does not necessarily mean that they are about to fall to what I would consider to be fair value let lone cheap levels as they did during March 2020 because at the end of the day they are GOOD stocks so usually command a healthy premium to invest in.

However, during the course of this exercise I am repeatedly finding that the biotech stocks are tending to be greatly unloved! Especially when one compares them to the barmy valuations that many of the smaller cap tech stocks that populate the likes of ARK INVEST have been lifted to such as TESLA and SQAURE and most of the rest.

So this does appear to be an opportune time to go on the hunt for smaller cap higher risk biotech stocks.

RISK RATINGS

I am also adding a risk rating to the high risk stocks where 1 is lowest risk and 10 highest risk in terms of something going wrong and the stock effectively crashing into becoming a penny stock or even going bust within the next 5 years. This is based on the sum of all my analysis of each stock and given my risk averse nature then most of the stocks will have a low probability of actually going bust within the next 5 years. Still this rating will give an extra measure of risk vs reward when entertaining potential position sizes.

Neurocrine Biosciences - NBIX - Low Risk Biotech X10 Stock

This biotech stock is focused on treating neurological and endocrine disorders and has been around since 1992, so has stood the test of time, trades on a market cap of $8.8bn and a PE of 22 so the stock at least makes a profit. The company shows consistent revenue growth though profits are erratic, estimated earnings growth for the next 3 years is 30%. The company has good debt to equity ratio of just 26.7%. So for a small cap high risk stock the company looks rock solid!

The stocks in a strong trading range of $135 to $70 pending a breakout HIGHER. Current price puts the stock right near support so AT a buying level right now primed for another run at the high! This price pattern is not what one would expect to see in a high risk stock which is a function of the fact that the pharma sector is unloved! So what do you think is going to happen to the stock price when the sector becomes loved with stocks such as this flying as high as the tech sector is right now to trade on 100X+ earnings! That's X5 NBIX's current price without any increase in earnings! For the biotech stocks have just as much future potential as the tech sector has! As for buying levels I would say right now at $92 is a buying level, then not too distant is $84, and then a more distant $74.

The bottom line is NBIX has been around for decades so has a good track record, and is fairly priced right now and is trading AT a buying level. So I am a buyer of NBIX! as it definitely has the potential to X10 with little downside risk to $70 at the worst against $92. I don't think the stock is going to stick around current levels for long.

This article is an excerpt from my recent extensive analysis that concludes in my latest biotech stocks with the potential to X10 over the coming years Five More Small Cap Bio and Tech Stocks to Invest for 2021 and Beyond! has first been made available to Patrons who support my work.

Topics Include:

Invest and Forget
Stock Market Early Summer Correction Review
AI Stocks Strength vs Weakness
RAMPANT MONEY PRINTING INFLATION BIG PICTURE!
HIGH RISK STOCK BUYING LEVELS
RISK RATINGS
WESTERN DIGITAL - WDC $71 - CHIA! - Risk 1
Life Sciences Biotech Smaller Cap High Risk Stocks Investing Binge
Biotech stock 1 - Cheap Low Risk Pharma - Risk 1
Biotech stock 2 - HIGH RISK GENE EDITING - Risk 9
Biotech stock 3 - Low Risk 2
Biotech stock 4 - X10 for Max Risk 10
High Risk Stocks Portfolio Buying Levels
Covid India Black Mold Epidemic
Bitcoin and Raven Coin Buying Levels

So for immediate first access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

Inlcuding access to my latest analysis -

Bitcoin Bear Market Trend Forecast 2021 and Model Crypto Portfolio Buying Levels

Investing in the Tulip Crypto Mania
Bitcoin Price Trend Forecast Review
Lessons Learned
Cathy Crypto Wood's View on Bitcoin
BITCOIN HALVINGS TREND TRAJECTORY
Stock to Flow Infinity and Beyond!
Bitcoin, Crypto's and the Inflation Mega-trend
Black Swan 1 - Will Crypto's Get Banned?
Black Swan 2 - GOOGLE
Black Swan 3 - USDT Tether Un-Stable Coin Ponzi Schemes!
BLACK SWAN 4 - Bitcoin 51% Network Attack by China?
Black Swan 5 - Bitcoin is Already Obsolete
US Trending Towards Hyperinflation
BITCOIN TREND ANALYSIS
Bitcoin Bear markets analysis - How low could she blow?
Bitcoin Trend Forecast
Bitcoin Long-term probable Next bull market price target
Alternative Scenarios
My Crypto Bear Market Investing Strategy
Crypto 1 - Ethereum (ETH) $2600
Crypto 2 - Bitcoin $40,375
Crypto 3 - Ravencoin $0.078
Crypto 4 - Cardano $1.59
Crypto 5 - Pokadot $25
Crypto 6 - ChainLink $26
Crypto's 7 to 10
Creating The Perfect Crypto
How to Invest in Crypto Without Getting SCAMMED
CHIA SCAM COIN
Binance vs Coinbase
Have ARK Invest Funds Bottomed?

My analysis schedule includes:

More X10 Biotech Tech Stocks - 60% done
UK House Prices Trend Analysis - 10% done
How to Get Rich! - 70% done
US Dollar and British Pound analysis
Gold and SIlver Price Analysis

Again for immediate access to all my work do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.\

And ensure you are subscribed to my ALWAYS FREE newsletter for my next in-depth analysis.

Your analyst investing in biotech stocks.

Nadeem Walayat

http://www.marketoracle.co.uk

Nadeem Walayat has over 30 years experience of trading derivatives, portfolio management and analysing the financial markets, including one of few who both anticipated and Beat the 1987 Crash. Nadeem's forward looking analysis focuses on UK inflation, economy, interest rates and housing market. He is the author of five ebook's in the The Inflation Mega-Trend and Stocks Stealth Bull Market series that can be downloaded for Free.

Nadeem is the Editor of The Market Oracle, a FREE Daily Financial Markets Analysis & Forecasting online publication that presents in-depth analysis from over 1000 experienced analysts on a range of views of the probable direction of the financial markets, thus enabling our readers to arrive at an informed opinion on future market direction. http://www.marketoracle.co.uk

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any trading losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors before engaging in any trading activities.

Nadeem Walayat Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.